Latest News
More News
-
It’s good to know: Lung cancer screening and the LGBTIQ+ community 10 February 2026 It’s good to know: Lung cancer screening and the LGBTIQ+ community Written by Professor Fraser Brims Consultant Respiratory Physician Sir Charles Gairdner Hospital Medical Advisor National Lung Cancer Screening Program Implementation WA Health Lung cancer is Australia’s leading cause of cancer death and for many in the LGBTIQ+ community, it is a bigger risk than most people realise. The new Australian National Lung Cancer Screening Program (NLCSP) is a major step forward because it can find lung cancer much earlier, when treatment is more likely to succeed and lives can be saved. For LGBTIQ+ people, who often face higher smoking rates and extra barriers to health care, this screening program is especially important as a chance to catch lung cancer sooner and reduce preventable deaths. Why lung cancer matters Lung cancer is the most common cause of cancer death in Australia, ... -
Professor Rajesh Thomas awarded 2025 Clinician Research Fellowship 09 February 2026 Congratulations to Professor Rajesh Thomas, Respiratory Medicine Consultant at Sir Charles Gairdner Hospital (SCGH), who has been awarded a 2025 Clinician Research Fellowship to optimise robotic bronchoscopy techniques. Professor Thomas said the fellowship aims to study how novel robotic bronchoscopy techniques could help to minimise the painful interventions, diagnostic delays and hospital admissions that our patients with lung cancer endure and thereby improve their care and cure. "This exciting project carries forward and expands on the new robotic bronchoscopy programme that my Interventional Bronchoscopy team has pioneered at Charlies," said Prof Thomas. The funding will support vital research into optimising robotic bronchoscopy techniques to improve lung cancer diagnosis-treatment, after SCGH became the first hospital in WA in July to establish a robotic bronchoscopy service. He s... -
Far North Clinic wins ECU Centre for Precision Health Consumer Engagement Award 05 February 2026 Congratulations to researchers from Mental Health Service's Neurosciences Unit, who were recently awarded the Edith Cowan University (ECU) Centre for Precision Health's Consumer Involvement in Research Prize for their ongoing work with the Far North Huntington's Mobile Clinic. The Far North Huntington’s Mobile Clinic is a consumer-led, co-designed project aiming to explore how to deliver neurological care on Country to Aboriginal families affected by Huntington’s disease. Senior Research Scientist Melanie Clark thanked her passionate team for going above and beyond for remote communities who often lack the resources and opportunities afforded to less remote areas. "I am incredibly proud of the team, achievement and the difference we are making in remote communities,” she said. “Far North Clinic trips are often the highlight of our year." Families are actively invo... -
Australian first surgery for lung cancer 03 February 2026 An Australian first surgery at Sir Charles Gairdner Hospital (SCGH) has enabled a patient with suspected lung cancer to have biopsies taken, cancer confirmed and removed all in one operation, under one anaesthetic. SCGH Executive Director Dr Jodi Graham thanked our innovative Respiratory Team for their dedication to enhance clinical care for lung cancer patients and identifying groundbreaking opportunities through evolving technology and precision medicine. “Our team is pioneering enhanced patient outcomes and I congratulate them on their vision of diagnosing and removing cancer within one anaesthetic,” Dr Graham said. Respiratory Medicine Consultant Dr Dhaval Thakkar led the ground-breaking surgery detecting the cancer deep in the lungs, before carrying out precision tissue sampling, and then highlighting the cancer with a glowing marker for a thoracic surgeon to easily loca... -
Cutting-edge treatment option for early-stage primary liver cancer 29 January 2026 Congratulations to A/Professor Colin Tang, Sir Charles Gairdner Hospital Radiation Oncology Consultant and Investigator, who recently presented at the Accuray Australasian Symposium on a cutting-edge treatment option for early-stage primary liver cancer. Prof Tang said his work explores whether stereotactic ablative body radiotherapy (SABR) could offer a safer, more effective treatment option for people with early-stage liver cancer. SABR is a highly precise form of radiation therapy that delivers high doses of radiation to tumours, while minimising damage to surrounding healthy tissue.An advanced robotic version of this technology is known as CyberKnife. Sir Charles Gairdner Hospital is home to the only public CyberKnife system in Australia, which can automatically track a tumour as it moves during treatment. Prof Tang said that this type of therapy shows strong potential for treating t...
Last Updated:
18/10/2023